FDA Approval Summary: Mobocertinib for Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
FDA批准摘要:Mobocertinib用于治疗EGFR 20号外显子插入突变的转移性非小细胞肺癌
期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-22-2072
Duke, Elizabeth S; Stapleford, Liza; Drezner, Nicole; Amatya, Anup K; Mishra-Kalyani, Pallavi S; Shen, Yuan-Li; Maxfield, Kimberly; Zirkelbach, Jeanne Fourie; Bi, Youwei; Liu, Jiang; Zhang, Xinyuan; Wang, Hezhen; Yang, Yuching; Zheng, Nan; Reece, Kelie; Wearne, Emily; Glen, Jacqueline J; Ojofeitimi, Idara; Scepura, Barbara; Nair, Abhilasha; Bikkavilli, Rama Kamesh; Ghosh, Soma; Philip, Reena; Pazdur, Richard; Beaver, Julia A; Singh, Harpreet; Donoghue, Martha